» Articles » PMID: 28894147

Intrinsic Property of Phenylalanine to Trigger Protein Aggregation and Hemolysis Has a Direct Relevance to Phenylketonuria

Overview
Journal Sci Rep
Specialty Science
Date 2017 Sep 13
PMID 28894147
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Excess accumulation of phenylalanine is the characteristic of untreated Phenylketonuria (PKU), a well-known genetic abnormality, which triggers several neurological, physical and developmental severities. However, the fundamental mechanism behind the origin of such diverse health problems, particularly the issue of how they are related to the build-up of phenylalanine molecules in the body, is largely unknown. Here, we show cross-seeding ability of phenylalanine fibrils that can effectively initiate an aggregation process in proteins under physiological conditions, converting native protein structures to β-sheet assembly. The resultant fibrils were found to cause severe hemolysis, yielding a plethora of deformed erythrocytes that is highly relevant to phenylketonuria. Unique arrangement of zwitterionic phenylalanine molecules in their amyloid-like higher order entities is predicted to promote both hydrophobic and electrostatic interaction, sufficient enough to trap proteins and to preferentially interact with the membrane components of RBCs. Since the prevalence of hemolysis and amyloid related psychoneurological severities are mostly observed in PKU patients, we propose that the inherent property of phenylalanine fibrils to trigger hemolysis and to induce protein aggregation may have direct relevance to the disease mechanism of PKU.

Citing Articles

A Diphenylalanine Based Pentapeptide with Fibrillating Self-Assembling Properties.

Jitaru S, Neamtu A, Drochioiu G, Darie-Ion L, Stoica I, Petre B Pharmaceutics. 2023; 15(2).

PMID: 36839694 PMC: 9966497. DOI: 10.3390/pharmaceutics15020371.


Induction of retinopathy by fibrillar oxalate assemblies.

Zaguri D, Shaham-Niv S, Naaman E, Mimouni M, Magen D, Pollack S Commun Chem. 2023; 3(1):2.

PMID: 36703385 PMC: 9812261. DOI: 10.1038/s42004-019-0247-8.


Non-Targeted Metabolomics Approach Revealed Significant Changes in Metabolic Pathways in Patients with Chronic Traumatic Encephalopathy.

Lee J, Kim S, Kim Y, Park U, Lee J, McKee A Biomedicines. 2022; 10(7).

PMID: 35885023 PMC: 9313062. DOI: 10.3390/biomedicines10071718.


Engineering Organoids for Modeling of Phenylketonuria.

Borges A, Broersen K, Leandro P, Fernandes T Front Mol Neurosci. 2022; 14:787242.

PMID: 35082602 PMC: 8784555. DOI: 10.3389/fnmol.2021.787242.


ASL expression in ALDH1A1 neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.

Lerner S, Eilam R, Adler L, Baruteau J, Kreiser T, Tsoory M Hum Genet. 2021; 140(10):1471-1485.

PMID: 34417872 PMC: 8460544. DOI: 10.1007/s00439-021-02345-5.


References
1.
Nakagawa K, Kiko T, Miyazawa T, Sookwong P, Tsuduki T, Satoh A . Amyloid β-induced erythrocytic damage and its attenuation by carotenoids. FEBS Lett. 2011; 585(8):1249-54. DOI: 10.1016/j.febslet.2011.03.060. View

2.
Pillot T, Goethals M, Vanloo B, Talussot C, Brasseur R, Vandekerckhove J . Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J Biol Chem. 1996; 271(46):28757-65. DOI: 10.1074/jbc.271.46.28757. View

3.
Kar K, Arduini I, Drombosky K, van der Wel P, Wetzel R . D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells. J Mol Biol. 2013; 426(4):816-29. PMC: 3910295. DOI: 10.1016/j.jmb.2013.11.019. View

4.
Kim D, Lim S, Haque M, Ryoo N, Hong H, Rhim H . Identification of disulfide cross-linked tau dimer responsible for tau propagation. Sci Rep. 2015; 5:15231. PMC: 4606741. DOI: 10.1038/srep15231. View

5.
Jayakumar R, Kusiak J, Chrest F, Demehin A, Murali J, Wersto R . Red cell perturbations by amyloid beta-protein. Biochim Biophys Acta. 2003; 1622(1):20-8. DOI: 10.1016/s0304-4165(03)00101-6. View